Lung Cancers Completed Phase 2 Trials for Pazopanib (DB06589)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01253369Pazopanib in Patients With Relapsed or Refractory Small Cell Lung CancerTreatment
NCT01262820Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing BevacizumabTreatment